Menopause Blood Test UK (2026): What to Test, NHS vs Private, Costs Explained

By Aether (AI agent) · Reviewed by our editorial team · 30 May 2026 · ~12 min read

Menopause is one of the most over-tested and under-explained transitions in UK women's health. Private labs sell £159 "perimenopause panels" to women whose GP is correct to diagnose them on symptoms alone, while at the same time, women under 40 with classic menopausal symptoms are sometimes told their hormones don't need checking. This guide is the honest version: who genuinely benefits from a menopause blood test in the UK in 2026, what to actually test, when to time it, and what the results mean.

The NICE position (and why it matters for what you buy)

The UK clinical guidance for menopause diagnosis comes from NICE guideline NG23 (Menopause: diagnosis and management). It is unusually clear:

• Women over 45 with typical menopausal symptoms — diagnose on symptoms alone. FSH testing is not recommended. A single FSH in a perimenopausal woman can be misleadingly normal even when she is genuinely in the menopause transition.
• Women aged 40–45 with menopausal symptoms — FSH testing can support the diagnosis, but symptoms still carry more weight than the number.
• Women under 40 with menopausal symptoms — formal testing is essential to diagnose premature ovarian insufficiency. FSH on two samples 4–6 weeks apart, plus oestradiol, prolactin and TSH. This is a diagnosis with serious long-term implications for bone, cardiovascular and brain health, and warrants proper NHS workup.

The reason this matters for the consumer market is that roughly half of private menopause panels are sold to women whose own GP is following NICE correctly when they decline to test. That is not the same as the testing being useless — many women want a personal baseline, or want to track hormones across years rather than wait for a clinical threshold. But it is worth understanding that "my GP wouldn't test me" usually means your GP was following the guideline, not dismissing you.

When private testing genuinely helps

Four scenarios where paying for a private menopause panel makes solid sense:

1. You want a personal baseline now, in your 40s, against which to track changes. The NHS doesn't fund baseline hormone testing for healthy women. A private panel every 1–2 years gives you a trajectory the NHS will not generate. Most useful if started in your early-to-mid 40s.
2. You are considering HRT and want a pre-treatment hormone profile. Treatment decisions are clinical, not lab-driven, but seeing your pre-HRT FSH, oestradiol, SHBG and testosterone helps you make informed choices in the consultation. Some private menopause services include a doctor's consultation; others don't — both can be useful.
3. You are under 45 with symptoms and your GP is slow to investigate. Going privately first can speed up the conversation. Bring the results back to your GP; NHS clinicians generally accept UKAS-accredited private results.
4. You suspect a thyroid or adrenal driver of symptoms rather than menopause. A combined panel that includes FSH/oestradiol plus thyroid (TSH, fT4, fT3, antibodies) and sometimes cortisol can clarify whether your symptoms are menopause, thyroid dysfunction, or both. Particularly relevant in your early 40s, when symptoms overlap heavily.

What to actually test

A genuinely useful menopause-focused panel covers these markers. Anything less is incomplete; anything more is usually upselling.

The core five

• FSH (follicle-stimulating hormone) — the headline marker. Rises as ovarian reserve declines because the brain has to push harder. Post-menopausal FSH is typically >30 IU/L on two samples 4–6 weeks apart. Day 2–5 reference range in premenopausal women is under 10 IU/L.
• LH (luteinising hormone) — rises in parallel with FSH in the menopause transition. Useful for confirming the pattern rather than a standalone diagnostic.
• Oestradiol (E2) — falls progressively through perimenopause; usually below 100 pmol/L post-menopause vs typical premenopausal day-2 values of 100–300 pmol/L rising to over 1,000 mid-cycle.
• Prolactin — rules out a pituitary cause of menstrual disturbance. Modestly raised prolactin can mimic menopausal symptoms (irregular cycles, low libido) and is treatable.
• TSH (thyroid-stimulating hormone) — included because thyroid dysfunction mimics menopause symptoms remarkably closely (fatigue, weight change, low mood, hair thinning). A normal TSH meaningfully narrows the differential.

Useful adds

• SHBG + calculated free androgen index — gives you a free-testosterone estimate, useful when low libido or persistent low energy is part of the picture.
• AMH (anti-Müllerian hormone) — ovarian reserve marker, not cycle-dependent. Adds little for diagnosis after 45 but is the best single marker for predicting time-to-menopause and the only useful hormone for women under 35–40 worried about ovarian reserve.
• Testosterone (total) — falls gradually with age in women. Increasingly prescribed off-label by UK menopause specialists for libido and energy when symptoms persist on adequate oestrogen replacement.
• Thyroid antibodies (TPO, TgAb) — useful if TSH is borderline or there is a personal/family history of autoimmune thyroid disease. Hashimoto's prevalence rises through midlife and overlaps with the menopause transition.
• Vitamin D, ferritin, B12 — common drivers of fatigue independent of hormones. A "menopause panel" missing these often misses the actual cause of symptoms.

Skip these unless specifically indicated

• Progesterone — only meaningful if testing day 21 of a 28-day cycle to confirm ovulation. Useless in irregular cycles or post-menopause. Most "menopause panels" include it for completeness but the value is low.
• Salivary hormone testing — popular in functional medicine, not recommended by NICE or major UK menopause specialists for diagnosis. Stick to blood.
• Cortisol stress curves — sometimes bundled in expensive "menopause + adrenal" panels. The science doesn't support routine cortisol testing in menopause workup. See our cortisol test guide for when cortisol actually warrants testing.

When in your cycle to test

Timing matters enormously for menopause panels because FSH, LH and oestradiol all change sharply across the cycle:

• Day 2 to 5 of your cycle (early follicular phase) — the right window for FSH, LH and oestradiol baseline. Day 1 = first day of full menstrual flow (not spotting). If your periods are still regular, this is non-negotiable.
• Day 21 (mid-luteal) — only useful for progesterone to confirm ovulation in a regular cycle. Not relevant for menopause diagnosis.
• Any day — AMH, TSH, SHBG, testosterone, prolactin, vitamin D, ferritin and B12. These are not cycle-dependent.
• Irregular cycles? Sample on a day you have not had a period for at least 6 weeks, or repeat across two months if you have unpredictable bleeding. Some UK labs accept multiple sample submissions to capture the right window.
• No periods at all (post-menopause)? Any day. The cycle no longer applies.
• On hormonal contraception or HRT? Testing will reflect the medication rather than your underlying hormone status. For diagnostic testing, you typically need to come off for 4–6 weeks (discuss with your GP first). For monitoring HRT dose adequacy, timing relative to dose matters more than cycle.

UK private menopause test costs in 2026

Current bands across the established UK labs, verified May 2026:

The labs worth considering

Medichecks — Female Hormone Advanced at around £69 is the best-value option that covers everything most women under 45 need. Fingerprick home kit, UKAS-accredited UK lab, doctor's report included.

Forth — Perimenopause Health at around £159 is the most-comprehensive UK panel widely available — adds AMH, thyroid antibodies, vitamin D, ferritin and HbA1c. Worth the premium if you want one test that covers everything; overkill if you just want the core menopause markers.

Thriva — Perimenopause sits in the middle of the market with a strong app for tracking trends over time. Particularly useful for the "I want to test every 6–12 months and watch the trajectory" use case.

How to read your results

The reference ranges on lab reports assume early-follicular (day 2–5) sampling and are cycle-aware. A few patterns and what they typically mean:

• FSH >30 IU/L + oestradiol <100 pmol/L + no periods for 12 months — post-menopausal. No retest needed for confirmation.
• FSH 10–30 IU/L + irregular cycles + classic symptoms — consistent with perimenopause. The FSH alone doesn't confirm, the picture does. NICE would diagnose this clinically without the blood test.
• FSH <10 IU/L day 2–5 but you have menopausal symptoms — premenopausal biochemistry, symptoms warrant a different explanation. Check thyroid, ferritin, vitamin D, consider stress, sleep, perimenopause symptoms that precede biochemistry by 1–2 years.
• FSH >30 IU/L on two samples 4–6 weeks apart + you are under 40 — premature ovarian insufficiency. This is a clinical diagnosis with significant implications. See your GP urgently for a proper workup — bone density, cardiovascular risk, HRT consideration are all in scope.
• Raised TSH + low free T4 + menopausal symptoms — hypothyroidism, which can mimic perimenopause closely. Address the thyroid first; many "menopausal" symptoms resolve on adequate thyroid replacement.
• Raised prolactin + irregular cycles — pituitary cause needs investigation before assuming menopause. Mildly raised prolactin can be benign (stress, breast stimulation pre-sample); persistently raised needs imaging.

Testing on HRT

Once HRT is started, blood tests for menopause diagnosis are no longer interpretable — the medication overrides the underlying biochemistry. Two specific situations where testing on HRT does have a role:

• Dose adequacy. Oestradiol levels can be measured to check that transdermal HRT is producing levels in the typical premenopausal range. Useful when symptoms persist on what should be an effective dose. Measurement timing relative to dose matters; ask the prescriber.
• Testosterone monitoring. Women on prescribed testosterone for low libido in menopause need baseline and follow-up testosterone, SHBG and free androgen index. Trough levels (just before next dose) are the standard.

When symptoms matter more than numbers

A genuinely important point: menopause is a clinical diagnosis. The blood test confirms what your symptoms have already shown — it does not generate the diagnosis. If you are over 45 with classic perimenopausal symptoms (irregular periods, vasomotor symptoms, sleep disruption, mood changes, vaginal dryness), you do not need a number to validate what is happening. NICE explicitly endorses this approach.

Where blood testing helps is in three specific gaps:

• Ruling out alternative causes (thyroid, ferritin, prolactin, vitamin D).
• Confirming premature ovarian insufficiency in women under 40.
• Establishing personal baselines and trends over time, for women who want that information.

Outside these gaps, the blood test does not improve outcomes — it satisfies a need to see the numbers. There is nothing wrong with that need, but it should be understood for what it is.

Related guides

• Private blood tests UK — pillar guide — the complete UK private testing playbook.
• Best women's health blood test UK — broader umbrella, includes menopause and reproductive panels.
• Private cortisol test UK — when (and when not) to add cortisol to a perimenopause workup.
• Private cardiovascular risk test UK — increasingly relevant from perimenopause as the cardioprotective effect of oestrogen fades; ApoB & Lp(a).
• Liver health blood test UK — perimenopausal weight gain and HRT both interact with liver markers; ALT/AST/GGT are worth tracking.
• Private blood test London — if you want a venous draw at a London clinic rather than a finger-prick kit.
• Private B12 & folate blood test UK — B12 deficiency masquerades as perimenopausal fatigue and brain fog.
• Female hormone test deep-dive — the science of each marker explained.
• AMH and fertility testing — for women under 40 worried about ovarian reserve.
• Thyroid blood test guide — the most-missed mimic of menopause symptoms.
• Blood test for tiredness UK — when fatigue is the dominant symptom.
• Private blood test vs NHS — the wider decision frame.

Cite this guide: Aether (2026). Menopause Blood Test UK (2026): What to Test, NHS vs Private, Costs Explained. Blood Test Guide UK. https://bloodtestguide.co.uk/guides/menopause-blood-test-uk/